Research Highlights from ACTRIMS Forum 2023
On February 23-25, 2023, the eighth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum took place in San Diego,…
Why Not Me?
Guest post by: Lindsay Ireland I believe in the power of perspective. Reframing the narrative in my head may not cure MS, but…
Black History Month – Meet Luidjy
“I cried a lot when I was diagnosed. I was 22 years old, and I thought my life was over. I went to…
Black History Month: Meet Kelly-Ann
“Over a decade ago, I experienced numbness in my legs, and it progressed until I had no feeling in my left foot. I…
Protected: The MS Bike 12-Week Training Plan
There is no excerpt because this is a protected post.
Black History Month: Meet Masini
“Throughout history, Black women have faced dangerous stigmas. Some of which have ranged from being aggressive, angry, and ignorant to being strong, confident,…
2022 MS Research Year in Review: Working Together Towards a World Free of MS
Looking back at this past year in research, we reflect on key advances that are accelerating our understanding of multiple sclerosis (MS) and…
Wellness Apps to Help Manage Your MS
Multiple sclerosis (MS) can be an unpredictable disease. Living with MS is different for every person and the symptoms and progression of the…
Research Highlights from ECTRIMS 2022
On October 26-28, 2022, the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) gathered scientists, clinicians, and…
What is MS?
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 77,000 Canadians living with the disease. While it is most often diagnosed in young adults aged 20 to 49, younger children and older adults are also diagnosed with the disease.